Soiken Holdings Inc. (TYO:2385)
217.00
0.00 (0.00%)
Oct 26, 2026, 3:30 PM JST
Soiken Holdings Revenue
In the fiscal year ending June 30, 2026, Soiken Holdings had annual revenue of 3.87B JPY, down -20.15%. Soiken Holdings had revenue of 635.00M in the quarter ending June 30, 2026, a decrease of -45.63%. That makes Soiken Holdings the 32,575th largest company in the world by revenue and 3,403rd in Japan.
Revenue
3.87B
Revenue Growth
-20.15%
P/S Ratio
1.47
Revenue / Employee
86.02M
Employees
45
Market Cap
5.68B
Revenue by Segment
Fiscal year ended Jun 30, 2026 See the full Soiken Holdings breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 3.87B | -977.00M | -20.15% |
| Jun 30, 2025 | 4.85B | -310.00M | -6.01% |
| Jun 30, 2024 | 5.16B | -2.92B | -36.16% |
| Jun 30, 2023 | 8.08B | -1.27B | -13.57% |
| Jun 30, 2022 | 9.35B | 405.00M | 4.53% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CellSource | 3.67B |
| StemCell Institute | 2.81B |
| MEDINET | 998.00M |
| PRISM BioLab Co.,LTD | 737.27M |
| Chiome Bioscience | 615.15M |
| SUSMED,Inc. | 497.00M |
| Kringle Pharma | 342.21M |
| Cyfuse Biomedical K.K. | 305.00M |